NEWARK, Del.--(BUSINESS WIRE)--Aug 19, 2025--
CorriXR Therapeutics, Inc., a pioneering oncology-focused biotherapeutics company, has announced a significant milestone with a $1M investment from the State of Delaware. This funding will be instrumental in advancing CorriXR’s lead program aimed at developing next-generation treatments for solid tumors, with particular focus on head and neck, and lung cancers. This investment not only underscores the potential of CorriXR’s cutting-edge therapies but also highlights Delaware’s commitment to supporting innovative early-stage companies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819018203/en/
"We’re excited to have the State of Delaware participate in our Series A financing round as we advance toward our first-in-human clinical trial,” said Eric Kmiec, Ph.D., founder & CEO of CorriXR. “This investment will be critical as we complete preclinical studies, scale-up manufacturing, and prepare our investigational new drug (IND) submission.”
The State of Delaware’s investment in CorriXR is the first $1M investment from the Delaware Accelerator & Seed Capital Program (DASCP), one of four programs awarded under the State Small Business Credit Initiative (SSBCI) federal program from the U.S. Treasury Department. The Division of Small Business is administering Delaware’s $60.9 million SSBCI award aimed at providing access to capital for start-up and early-stage businesses.
“Our first $1 million investment is proof that Delaware’s path to becoming the Mid-Atlantic hub for Innovation is well underway,” said Delaware Division of Small Business Director CJ Bell. “Supporting companies like CorriXR to scale isn’t just good business – it’s the blueprint for turning that vision into reality.”
“This is how Delaware wins the future, with CorriXR demonstrating the power of turning research into real solutions," said Delaware Governor Matt Meyer. "By working closely with experts at the Gene Editing Institute, CorriXR is making promising CRISPR therapies a reality for patients faster than ever. This is exactly why the SSBCI program exists—because supporting innovation today means better treatments, stronger businesses, and a brighter future for Delaware."
About CorriXR Therapeutics
CorriXR is developing genetic medicines to transform the treatment of solid tumors. CorriXR’s patented non-viral gene editing tool disables transcription factor NRF2, which controls 200+ genes responsible for creating a pro-oncogenic tumor microenvironment. Knockout of NRF2 disrupts cancer cell survival mechanisms and sensitizes them to standard of care, and is being developed as a monotherapy, neoadjuvant or in combination with chemotherapy, radiotherapy, or immunotherapy. CorriXR's platform has potential applications in over 30 types of squamous cell carcinomas by improving treatment efficiency at lower doses, increasing patient eligibility, and reducing dropouts due to side effects—ultimately leading to improved patient outcomes.
Learn more at www.corrixr.com.
Delaware Governor Meyer (far right) and Delaware Division of Small Business Director Bell (center) join the CorriXR leadership team to announce the state's $1M investment in the company.
AL HENAKIYAH, Saudi Arabia (AP) — Ricky Brabec deliberately gave up his motorbike lead over Luciano Benavides in the Dakar Rally while Nasser Al-Attiyah was happy to cruise through another day closer to his sixth car title on Thursday.
Al-Attiyah started 346-kilometer stage 11 between Bisha north to Al Henakiyah with a 12-minute overall lead and let it drop to less than nine minutes over new second-placed driver Nani Roma in a Ford.
Al-Attiyah was content to let Dacia teammate Sébastien Loeb catch up and pass him to have a teammate nearby for any help and to minimize errors on the mazy, dirt track. Al-Attiyah was 17th, nearly 13 minutes behind stage winner Mattias Ekström, and said he needed to execute the same plan on Friday's last effective racing stage before the end on Saturday.
“If we lose two, three, four minutes no problem,” Al-Attiyah said. “We just need to finish this Dakar in first place.”
Honda cooked up a strategy in the Saudi desert for Adrien van Beveren to open the way and let Brabec catch up after the 190-kilometer pit stop and pick up time bonuses.
Brabec boosted his overall lead from 56 seconds to nearly four minutes just 25 kilometers from the finish. He was also within a minute of the stage lead but he slowed down so KTM rival Benavides was the new overall leader, but only by 23 seconds.
Brabec got his his wish to start Friday's stage 12 six minutes behind Benavides, so he can eye him. They head west to the rally starting point of Yanbu on the Red Sea coast on 311 kilometers of gravel, some river beds with a finish in the dunes.
“A little bit of strategy today and hopefully it pays off tomorrow,” Brabec said. "I feel like its going to be a good day. We’re going back into the rocks so it will be a little bit better for us.”
Brabec is counting on his experience of winning the Dakar in 2020 and 2024 to trump Benavides, who has a best placing of fourth last year.
“I've been in this situation before,” Brabec said. “For the whole two weeks I've been just trying to stay relax, stay comfortable and just be confident, so two days more. I'm gonna do the same thing tomorrow that I've been doing every day; ride dirt bikes and have fun.”
Van Beveren helped Brabec with navigation while fighting with another teammate, Skyler Howes, the entire day for the stage win.
Howes prevailed by 21 seconds for his first career major stage in his eighth Dakar. He was third in 2023 and sixth last year. He's running fifth, 34 minutes off the pace.
Benavides was fourth in the stage and believed the race will be decided on the final 105-kilometer sprint on Saturday.
“I played no strategy like Ricky. I don't care,” Benavides said. “I'm doing what I can to control what I can control.”
Ekström won his third car stage of this Dakar, a special so fast that 12 other drivers were within 10 minutes.
Ford achieved another 1-2-3 stage. Romain Dumas, a three-time winner of the Le Mans 24 Hours, was a career-best second just over a minute back and Carlos Sainz was third.
Only Toyota's Henk Lategan beat Ekström to a checkpoint but Lategan's podium hopes were wrecked after 140 kilometers when a bearing broke on his rear left wheel. Lategan was second last year and second overall overnight but he plunged out of the top 15, at least.
Loeb moved up to third overall, 10 minutes behind Roma and three minutes ahead of Ekström.
AP auto racing: https://apnews.com/hub/auto-racing
Rider Daniel Sanders competes during the eleventh stage of the Dakar Rally between Bisha and Al Henakiyah, Saudi Arabia, Thursday, Jan.15, 2026. (AP Photo/Thibault Camus)
Driver Nasser Al-Attiyah and co-driver Fabian Lurquin compete during the eleventh stage of the Dakar Rally between Bisha and Al Henakiyah, Saudi Arabia, Thursday, Jan.15, 2026. (AP Photo/Thibault Camus)
Rider Skyler Howes competes during the eleventh stage of the Dakar Rally between Bisha and Al Henakiyah, Saudi Arabia, Thursday, Jan.15, 2026. (AP Photo/Thibault Camus)
Driver Henk Lategan, left, and co-driver Brett Cummings repair their car during the eleventh stage of the Dakar Rally between Bisha and Al Henakiyah, Saudi Arabia, Thursday, Jan.15, 2026. (AP Photo/Thibault Camus)
Driver Nani Roma and co-driver Alex Haro compete during the eleventh stage of the Dakar Rally between Bisha and Al Henakiyah, Saudi Arabia, Thursday, Jan.15, 2026. (AP Photo/Thibault Camus)
